Evidence map›Paper›PMID 27780200›Full record

ArticlePloS one2016

Neisserial Heparin Binding Antigen (NHBA) Contributes to the Adhesion of Neisseria meningitidis to Human Epithelial Cells.

Irene Vacca, Elena Del Tordello, Gianmarco Gasperini, Alfredo Pezzicoli, Martina Di Fede, Silvia Rossi Paccani, Sara Marchi, Tsisti D Mubaiwa, Lauren E Hartley-Tassell, Michael P Jennings and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Characterisation and Immunogenicity ofFrontiers in immunology · 2024
    Article
  6. Multilayer Regulation ofMicroorganisms · 2022
    Article
  7. The Host-Pathogen Interactions and Epicellular Lifestyle ofFrontiers in cellular and infection microbiology · 2022
    Review
  8. Article
  9. Review
  10. TheVaccines · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Irene VaccaGSK Vaccines, Siena, Italy.
Elena Del TordelloGSK Vaccines, Siena, Italy.
Gianmarco GasperiniGSK Vaccines, Siena, Italy.
Alfredo PezzicoliGSK Vaccines, Siena, Italy.
Martina Di FedeGSK Vaccines, Siena, Italy.
Silvia Rossi PaccaniGSK Vaccines, Siena, Italy.
Sara MarchiGSK Vaccines, Siena, Italy.
Tsisti D MubaiwaInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Lauren E Hartley-TassellInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Michael P JenningsInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Kate L SeibInstitute for Glycomics, Griffith University, Gold Coast, Queensland, Australia.
Vega MasignaniGSK Vaccines, Siena, Italy.
Mariagrazia PizzaGSK Vaccines, Siena, Italy.
Davide SerrutoGSK Vaccines, Siena, Italy.
Beatrice AricòGSK Vaccines, Siena, Italy.
Isabel DelanyGSK Vaccines, Siena, Italy.
Toscana Life Sciences · ITGriffith University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neisserial Heparin Binding Antigen (NHBA) is a surface-exposed lipoprotein ubiquitously expressed by Neisseria meningitidis strains and an antigen of the Bexsero® vaccine. NHBA binds heparin through a conserved Arg-rich region that is the target of two proteases, the meningococcal NalP and human lactoferrin (hLf). In this work, in vitro studies showed that recombinant NHBA protein was able to bind epithelial cells and mutations of the Arg-rich tract abrogated this binding. All N-terminal and C-terminal fragments generated by NalP or hLf cleavage, regardless of the presence or absence of the Arg-rich region, did not bind to cells, indicating that a correct positioning of the Arg-rich region within the full length protein is crucial. Moreover, binding was abolished when cells were treated with heparinase III, suggesting that this interaction is mediated by heparan sulfate proteoglycans (HSPGs). N. meningitidis nhba knockout strains showed a significant reduction in adhesion to epithelial cells with respect to isogenic wild-type strains and adhesion of the wild-type strain was inhibited by anti-NHBA antibodies in a dose-dependent manner. Overall, the results demonstrate that NHBA contributes to meningococcal adhesion to epithelial cells through binding to HSPGs and suggest a possible role of anti-Bexsero® antibodies in the prevention of colonization.

Indexed as

Bacterial AdhesionAntibodies, BacterialBacterial Outer Membrane ProteinsBinding SitesCarrier ProteinsCell LineEpithelial CellsGene Knockout TechniquesHeparan Sulfate ProteoglycansHeparinHumansLactoferrinMembrane Transport ProteinsMeningococcal InfectionsMutationNeisseria meningitidisAntibodies, BacterialBacterial Outer Membrane ProteinsCarrier ProteinsHeparan Sulfate ProteoglycansHeparinLactoferrinLTF protein, humanMembrane Transport ProteinsNalP protein, Neisseria meningitidisNHBA protein, Neisseria meningitidisRecombinant ProteinsSerine Endopeptidases

Identifiers

PMID27780200
PMCPMC5079597
OpenAlexW2535836871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.